SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-133581
Filing Date
2014-04-07
Accepted
2014-04-07 16:31:09
Documents
20
Period of Report
2014-05-22
Effectiveness Date
2014-04-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d703513ddef14a.htm DEF 14A 901852
2 GRAPHIC g703513g22w18.jpg GRAPHIC 9803
3 GRAPHIC g703513g27u30.jpg GRAPHIC 19433
4 GRAPHIC g703513g29y13.jpg GRAPHIC 49517
5 GRAPHIC g703513g31n47.jpg GRAPHIC 9215
6 GRAPHIC g703513g36b03.jpg GRAPHIC 31601
7 GRAPHIC g703513g47h12.jpg GRAPHIC 32321
8 GRAPHIC g703513g49e55.jpg GRAPHIC 33102
9 GRAPHIC g703513g56p60.jpg GRAPHIC 4844
10 GRAPHIC g703513g56p94.jpg GRAPHIC 8899
11 GRAPHIC g703513g63m06.jpg GRAPHIC 8685
12 GRAPHIC g703513g68a57.jpg GRAPHIC 10017
13 GRAPHIC g703513g70m15.jpg GRAPHIC 8827
14 GRAPHIC g703513g71u18.jpg GRAPHIC 6213
15 GRAPHIC g703513g73a63.jpg GRAPHIC 22278
16 GRAPHIC g703513g79r30.jpg GRAPHIC 32943
17 GRAPHIC g703513g85f45.jpg GRAPHIC 9865
18 GRAPHIC g703513g86i52.jpg GRAPHIC 8863
19 GRAPHIC g703513g87s14.jpg GRAPHIC 10505
20 GRAPHIC g703513g88d60.jpg GRAPHIC 16029
  Complete submission text file 0001193125-14-133581.txt   1364478
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33137 | Film No.: 14748943
SIC: 2834 Pharmaceutical Preparations